Jean-Antoine Girault Selected Research

Jean-Antoine Girault Research Topics

Disease

13	Parkinson Disease (Parkinson's Disease) 01/2023 - 05/2004
10	Neoplasms (Cancer) 01/2022 - 03/2005
9	Dyskinesias (Dyskinesia) 01/2023 - 08/2004
8	Substance-Related Disorders (Drug Abuse) 01/2022 - 03/2003
4	Schizophrenia (Dementia Praecox) 01/2023 - 05/2013
3	Mental Disorders (Mental Disorder) 01/2023 - 06/2008
3	Huntington Disease (Huntington's Disease) 01/2019 - 08/2004
2	Autism Spectrum Disorder 01/2023 - 01/2018
2	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 01/2019
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2023
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Tauopathies 01/2021
1	Seizures (Absence Seizure) 01/2021
1	Cognitive Dysfunction 01/2019
1	Neuroinflammatory Diseases 01/2019
1	Anorexia 01/2019
1	Chorea (Rheumatic Chorea) 01/2019
1	Gliosis 01/2019
1	Memory Disorders (Memory Loss) 01/2019
1	Obesity 01/2019
1	Amyloid Plaque 01/2019
1	Dystonia (Limb Dystonia) 01/2017
1	Dystonic Disorders (Writer's Cramp) 01/2017
1	Wounds and Injuries (Trauma) 04/2016
1	Neoplasm Metastasis (Metastasis) 10/2015
1	Bone Resorption 01/2013
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2012
1	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 01/2011
1	Neurofibromatosis 2 (Neurofibromatosis Type II) 10/2008
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 08/2005
1	Tooth Diseases 02/2005
1	Hypersensitivity (Allergy) 08/2004
1	Psychotic Disorders (Schizoaffective Disorder) 05/2004
1	Fasciculation (Fasciculations) 10/2002

Drug/Important Bio-Agent (IBA)

8	Dopamine (Intropin)FDA LinkGeneric 10/2019 - 02/2007
7	Levodopa (L Dopa)FDA LinkGeneric 01/2023 - 08/2004
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021 - 08/2006
3	Phosphotransferases (Kinase)IBA 01/2019 - 06/2007
3	Focal Adhesion Protein-Tyrosine KinasesIBA 08/2012 - 08/2006
3	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 04/2012 - 02/2007
3	Proteins (Proteins, Gene)FDA Link 01/2011 - 02/2005
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2023 - 01/2019
2	Cocaine (Cocaine HCl)IBA 01/2022 - 01/2021
2	Dopamine Receptors (Dopamine Receptor)IBA 01/2022 - 05/2004
2	Amyloid (Amyloid Fibrils)IBA 01/2021 - 01/2019
2	Glutamic Acid (Glutamate)FDA Link 10/2019 - 01/2011
1	Extracellular Matrix ProteinsIBA 01/2023
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	Pilocarpine (Ocusert)FDA LinkGeneric 01/2021
1	Pentylenetetrazole (Metrazol)IBA 01/2021
1	Tamoxifen FDA LinkGeneric 01/2021
1	4,17 beta-dihydroxy-4-androstene-3-oneIBA 01/2021
1	Antidepressive Agents (Antidepressants)IBA 01/2019
1	Nerve Growth Factors (Neurotrophins)IBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	Prostaglandins BIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	CytokinesIBA 01/2019
1	tau Proteins (tau Protein)IBA 01/2019
1	Cyclin-Dependent Kinase 5IBA 01/2019
1	GhrelinIBA 01/2019
1	Glycoproteins (Glycoprotein)IBA 01/2018
1	GTP-Binding Proteins (G-Protein)IBA 01/2017
1	OxotremorineIBA 01/2017
1	Cholinergic Agents (Cholinergics)IBA 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2016
1	mitogen and stress-activated protein kinase 1IBA 11/2014
1	Messenger RNA (mRNA)IBA 04/2014
1	Antipsychotic Agents (Antipsychotics)IBA 04/2014
1	Haloperidol (Haldol)FDA LinkGeneric 04/2014
1	LigandsIBA 05/2013
1	Focal Adhesion Kinase 2IBA 01/2013
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2012
1	PhosphoproteinsIBA 01/2012
1	Protein Isoforms (Isoforms)IBA 01/2011
1	ChromatinIBA 03/2009
1	Transcription Factors (Transcription Factor)IBA 03/2009
1	Neurofibromin 2 (Merlin)IBA 10/2008
1	Histones (Histone)IBA 06/2007
1	Protein Kinases (Protein Kinase)IBA 06/2007
1	MitogensIBA 06/2007
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 06/2007
1	Methylphenidate (Ritalin)FDA LinkGeneric 08/2005
1	Dextroamphetamine (Dexedrine)FDA LinkGeneric 08/2005
1	Huntingtin ProteinIBA 06/2005
1	polyglutamineIBA 06/2005
1	Syndecan-3IBA 02/2005
1	Proteoglycans (Proteoglycan)IBA 02/2005
1	Dopamine D1 Receptors (Dopamine D1 Receptor)IBA 08/2004
1	GTP-Binding Protein alpha SubunitsIBA 08/2004
1	olfactory G protein subunit alpha olfIBA 08/2004
1	Therapeutic UsesIBA 05/2004
1	CannabinoidsIBA 03/2003
1	Dronabinol (THC)FDA LinkGeneric 03/2003
1	TenascinIBA 10/2002
1	Class 5 Receptor-Like Protein Tyrosine PhosphatasesIBA 10/2002
1	tenascin RIBA 10/2002

Therapy/Procedure

4	Therapeutics 01/2019 - 06/2007
1	Immunotherapy 01/2022